source
- HS-10504 Shows Promising Activity in EGFR C797S–Mutant NSCLC After TKI ResistancePhase 1 data show HS-10504 yields encouraging responses and manageable safety in EGFR C797S–mutant NSCLC post TKI therapy.onclive · 3mo ago↗ source
- Breast Cancer Experts Preview Abstracts to Watch at the 2026 ESMO Breast Cancer CongressExperts in a range of breast cancer subtypes highlight research data being presented at the 2026 ESMO Breast Cancer Congress.onclive · 3mo ago↗ source
- The Type of Fat—Not the Amount—Fuels Pancreatic CancerResearch from Yale Cancer Center showed that the type of fat consumed may matter more than amount in pancreatic cancer.onclive · 3mo ago↗ source